CMS to Resume Routine Nursing Home Inspections

Onsite revisit surveys, non-immediate jeopardy complaint surveys and annual recertification surveys will resume


The Centers for Medicare & Medicaid Services (CMS) will resume routine inspections for all Medicare- and Medicaid-certified providers and suppliers, after suspending them due to COVID, according to an article on the Skilled Nursing News website.

Onsite revisit surveys, non-immediate jeopardy complaint surveys and annual recertification surveys will resume as soon as resources are available.

In March, CMS ordered its state and regional surveyors to suspend “non-emergency" inspections across the country to allow inspectors to focus on infectious diseases and abuse, according to an article. on the HCPro website.

CMS locations were directed to suspend all enforcement actions except for unremoved Immediate Jeopardy citations.

Read the full Skilled Nursing News article.

 

 



August 27, 2020


Topic Area: Infection Control


Recent Posts

17 Million Patient Records Stolen in PIH Health Ransomware Attack

A ransomware attack halted operations across three of PIH’s hospitals.


Holidays are Prime Times for Healthcare Cyberattacks

A study found that 86 percent of organizations that experienced ransomware attacks were targeted on a holiday or weekend.


Hartford Healthcare Forms Partnership to Open Health Equity Clinic

The new clinic will open in January 2025.


UCHealth Reveals Plans for Memorial Hospital North Expansion

Construction on the patient tower is slated for 2026 with a projected opening to patients in 2029.


What Are 'Hospi-tels'?

Hospitals and hotels are partnering to better cater to patients and families.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.